Primary Squamous Cell Carcinoma Thyroid with Regional Recurrence
DOI:
https://doi.org/10.32539/bsm.v5i9.405Keywords:
Primary Squamous Cell Carcinoma, Thyroid Malignancy, Chemotherapy, Case ReportAbstract
Background. Primary squamous cell carcinoma (PSCC) of the thyroid is a very aggressive malignancy with a poor prognosis. There is no consensus for the management of primary squamous cell carcinoma (PSCC) of the thyroid, and this is based on rare cases in which the frequency of occurrence is less than 1% of thyroid malignancies. How squamous cell carcinoma originates in the thyroid gland is an interesting topic to discuss, because the thyroid gland does not have a squamous cell epithelium.
Case Presentation. A 43-year-old man was admitted to the DR Kariadi Hospital with complaints of a lump on the right neck. In June 2020, the patient complained of a lump in the right neck area with a diameter of about 1x1x1 cm, no pain. Ultrasound of the colli at the regional hospital showed the impression of multiple lymphadenopathy of the right colli level 2-5, and there were cystic nodules with solid parts in the right and left lobes of the thyroid suspected of being benign. An adenectomy operation was performed at a regional hospital and the impression of metastatic squamous undifferentiated carcinoma was obtained.
Conclusion. The management of thyroid PSCC is a multimodality therapy, namely surgery, chemotherapy and radiation.
Authors
- Nugroho Akhbar1*
- Benny Issakh2
- 1General Surgery Resident, Department of Surgery, Faculty of Medicine / Dr. Kariadi General Hospital, Diponegoro University, Semarang, Indonesia
- 2Staff of Oncology Division, Department of Surgery Dr. Kariadi General Hospital / Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Corresponding author Nugroho Akhbar — dr.nunug@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
